Literature DB >> 2338424

The clinical importance of all members of the Bacteroides fragilis group.

I Brook.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2338424     DOI： 10.1093/jac/25.3.473

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Prognostic factors and impact of antibiotherapy in 117 cases of anaerobic bacteraemia.

Authors:  R Robert; A Deraignac; G Le Moal; S Ragot; G Grollier
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-21       Impact factor: 3.267

2.  Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin.

Authors:  T O'Reilly; S Kunz; E Sande; O Zak; M A Sande; M G Täuber
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

3.  Electrophoretic analysis of the lipopolysaccharides of Bacteroides spp.

Authors:  J P Maskell
Journal:  Antonie Van Leeuwenhoek       Date:  1994       Impact factor: 2.271

4.  Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns.

Authors:  Kenneth E Aldridge; Deborah Ashcraft; Megan O'Brien; Charles V Sanders
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

5.  Expression of Bacteroides fragilis hemolysins in vivo and role of HlyBA in an intra-abdominal infection model.

Authors:  Leandro A Lobo; Audrey L Jenkins; C Jeffrey Smith; Edson R Rocha
Journal:  Microbiologyopen       Date:  2013-02-26       Impact factor: 3.139

Review 6.  Clinical review: bacteremia caused by anaerobic bacteria in children.

Authors:  Itzhak Brook
Journal:  Crit Care       Date:  2002-05-09       Impact factor: 9.097
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.